Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 1,501–1,600 of 2,013
Yamaguchi, M., Kajiya, H., Egashira, R., Yasunaga, M., 萩尾, 佳., Sato, A., Toshimitsu, T., Naito, T., & Ohno, J. (2018) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.27.199 · Cited by 5
Biologia Futura: four questions about ageing and the future of relevant animal models
Kubinyi, E. (2022) · Biologia Futura · doi:10.1007/s42977-022-00135-2 · Cited by 5
“three or more in humans instead of two), shortened telomeres (non-coding regions at the tips of chromosomes), and changes in several genes’ expression levels (Rodier and Campisi 2011).”
BackgroundThe dynamic nature of ageing: novel findings, therapeutic avenues and medical interventions
Chmielewski, P. P. (2020) · Anthropological Review · doi:10.2478/anre-2020-0001 · Cited by 4
Shirakawa, J., Ntege, E. H., Takemura, M., Miyamoto, S., Kawano, T., Sampei, C., Kawabata, H., Nakamura, H., Sunami, H., Hayata, T., et al. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.05.004 · Cited by 4
Cellular Senescence Program is Sensitive to Physical Differences in Polymeric Tissue Scaffolds
Yadav, P., Shah, R., Roy, A., Jani, S., Chatterjee, K., & Saini, D. K. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00057 · Cited by 5
Xu, D., Chen, X., Wu, M., Bi, J., Xue, H., & Chen, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28278 · Cited by 6
“Intricate mechanisms like the reduction of telomere length or clashes in growth signals compel atypical cells to transition into the irreversible G0 phase, thereby halting their growth and preventing endless multiplication of cancer cells [25 – 27].”
BackgroundZhao, D., Chen, J., Wang, Y., Zhang, L., Zhang, J., Zhang, W., Fan, J., Li, J., & Zhan, Q. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23306 · Cited by 4
Machine learning-based morphological quantification of replicative senescence in human fibroblasts
Welter, E. M., Benavides, S., Archer, T., Kosyk, O., & Zannas, A. S. (2023) · GeroScience · doi:10.1007/s11357-023-01007-w · Cited by 7
Takahashi, C., Okabe, E., Nono, M., Kishimoto, S., Matsui, H., Ishitani, T., Yamamoto, T., Uno, M., & Nishida, E. (2024) · Aging · doi:10.18632/aging.206111 · Cited by 6
Ghneim, H. K., Alfhili, M. A., Al-Harbi, S. O. E., Alhusayni, S. M., Abudawood, M., & Al‐Sheikh, Y. A. (2022) · General Physiology and Biophysics · doi:10.4149/gpb_2022024 · Cited by 4
He, L., Li, M., Liu, Z., & Padhiar, A. A. (2023) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2023.03.107 · Cited by 4
Age-related functional decline of human B cells
Fujiki, T., Matsumoto, S., Kishihara, K., & Katakura, Y. (2022) · Cytotechnology · doi:10.1007/s10616-021-00513-z · Cited by 5
“Indeed, it has been suggested that B cells in old individuals may have a decreased function due to cellular senescence, and that the SASP may have implications in various diseases (Yang et al. 2006; Coppé et al. 2008; Rodier and Campisi 2011).”
BackgroundRelation Between Cellular Senescence and Liver Diseases
Li, G., Yang, X., Fu, N., Ouyang, Y., & Qing, K. (2016) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(16)30036-0 · Cited by 4
Analysis of the senescence secretome during zebrafish retina regeneration
Konar, G. J., Vallone, K. T., Nguyen, T. D., & Patton, J. G. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1569422 · Cited by 5
Fontanilla-Ramirez, P., Willaume, S., Thezé, B., Moussa, A., Pennarun, G., & Bertrand, P. (2020) · médecine/sciences · doi:10.1051/medsci/2020241 · Cited by 6
Santín-Márquez, R., Salas-Venegas, V., García, J. A., Librado‐Osorio, R., Luna‐López, A., López‐Díazguerrero, N. E., Gómez‐González, B., & Königsberg, M. (2025) · Biogerontology · doi:10.1007/s10522-025-10231-0 · Cited by 5
“Senescent cells are cells that irreversibly stop their proliferation in response to a stressor stimulus (Toussaint, et al. 2000; Rodier & Campisi 2011), and secrete a set of proinflammatory molecules known as SASP (Senescence-associated secretory phenotype (Rodier et al 2009; Maciel-Barón et al.…”
Pathogenesis and prevention of skin aging
Cho, S. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.6.438 · Cited by 4
“세포노쇠 표지 자로는 p16, p21, p53 발현, senescence-associated β-galactosidase 활성 증가가 있다[26].”
If ageing is a disease, then life is also a disease
Chmielewski, P. P., & Strzelec, B. (2020) · Anthropological Review · doi:10.2478/anre-2020-0017 · Cited by 4
Muda, M. (2011) · Cell Cycle · doi:10.4161/cc.10.17.16574 · Cited by 4
Santos‐Sousa, D., da Rosa, S., & Filippi‐Chiela, E. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112052 · Cited by 9
The Emergence of GeroMIRs: A Group of MicroRNAs Implicated in Aging
Ugalde, A. P., Kwarciak, A., Caravia, X. M., López-Otín, C., & Ramsay, A. J. (2013) · Wiley eBooks · doi:10.1002/9781118300312.ch5 · Cited by 5
Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP)
Malaquin, N., & Rodier, F. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.10.005 · Cited by 8
Self-citationYamada, T., KAMIYA, M., & HIGUCHI, M. (2020) · Animal Science Journal · doi:10.1111/asj.13443 · Cited by 5
Liu, Q., Jing, D., Li, Y., Yao, B., Zhang, H., Wang, L., Wu, C., Wang, X., & Li, L. (2024) · Placenta · doi:10.1016/j.placenta.2024.09.008 · Cited by 5
Iswarya, B. R., & John, C. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10904-6 · Cited by 5
“SASP-conditioned media (SASP-CM) was collected from senescent A549 cells following the protocol by Rodier et al. (2012) [14].”
Lissa, D., Joruiz, S. M., Dranchak, P. K., Ungerleider, K., Yamada, L., Horikawa, I., Oliphant, E. N., Manubag, R., von Muhlinen, N., Beck, J. A., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00186 · Cited by 5
Wen, J., Liu, J., Wan, L., & Wang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1620209 · Cited by 7
“Cellular senescence refers to a permanent halt in the cell cycle caused by various stress factors (such as DNA damage, telomere shortening, oncogene activation, and oxidative stress) (101).”
Rožman, P. J., Jazbec, K., & Jež, M. (2018) · InTech eBooks · doi:10.5772/intechopen.71764 · Cited by 6
“Among other functions, the senescent cells manifest dramatic alterations in their secretome, which is particularly enriched in pro-inflammatory cytokines and matrix metalloproteinases, which is referred to as the “senescence-associated secretory phenotype” [249, 250].”
BackgroundMonochromosomal Hybrids and Chromosome Transfer: A Functional Approach for Gene Identification
Kandpal, R. P., Sandhu, A., Kaur, G., Kaur, G. P., & Athwal, R. S. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20022 · Cited by 3
Impact of temperature and photoperiod on survival and biomarkers of senescence in common woodlousePreprint
Depeux, C., Samba‐Louaka, A., Braquart‐Varnier, C., Moreau, J., Lemaître, J., Laverré, T., Pauhlac, H., Dechaume‐Moncharmont, F., Gaillard, J., & Beltran‐Bech, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/433011 · Cited by 4
“Moreover, senescent cells are bigger than non-senescent cells (Hayflick, 1965; Rodier and Campisi, 2011).”
BackgroundNutrigenomics and Nutrigenetics
Corcuff, J., & Merched, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00003-0 · Cited by 3
Effects of molecular interactions between the exposome and oxylipin metabolism on healthspan
Hinman, J., Alan, J. K., & Lee, K. S. S. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1584195 · Cited by 3
Yang, X., Ma, A., Liu, Y., He, Z.-C., Yu, J., Su, S., Chen, J., & Sang, A. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110588 · Cited by 3
Alexander, E. T., Barone, K. S., & Gilmour, S. K. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.70034 · Cited by 4
“Cellular senescence is established and maintained by upregulation of cell cycle inhibitors such as p16 [50, 51], and we found FIGURE 2 | GCN2 pathway activated in dermal fibroblasts of K6ODC transgenic mice.”
The Multifaceted Phenotype of Senescent HL-60/S4 MacrophagesPreprint
Olins, A. L., Welch, D. B. M., Saul, D., Prudovsky, I. A., & Olins, D. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.15.598082 · Cited by 3
“…of irreversibly blocked replication (cell-cycling), while displaying senescence biomarkers, such as increased b -galactosidase, and generally exhibiting an absence of apoptotic death (Herranz and Gil, 2018; Hu et al., 2022; Huang et al., 2022; Rodier and Campisi, 2011; Soto-Gamez et al., 2019).”
BackgroundTelomerase-active urine-derived stem cells: Regenerative solutions for aging
Cheng, X., Fu, Q.-Y., Zheng, Y., Moiseyev, G. P., Hsu, F., Ma, J., Li, Q., Atala, A., & Zhang, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102939 · Cited by 5
UBC9-mediated p53 SUMOylation drives tubular senescence and exacerbates acute kidney injury in mice
Wu, Q.-M., Liu, J., Mu, Y., Li, J., Tian, Y.-J., Wang, Z., Deng, M., Qiu, Y.-M., Zhou, S., Zhang, Z., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01715-3 · Cited by 4
Aged-senescent cells contribute to impaired heart regeneration
(2018) · doi:10.1101/397216 · Cited by 317
Moderate stem-cell telomere shortening rate postpones cancer onset in a stochastic model
Holbek, S., Bendtsen, K. M., & Juul, J. (2013) · Physical Review E · doi:10.1103/physreve.88.042706 · Cited by 3
Effect of daikenchuto (TU-100) on carcinogenesis in non-alcoholic steatohepatitis
Yamada, S., Morine, Y., Imura, S., Ikemoto, T., Saito, Y., Ichimura‐Shimizu, M., Tsuneyama, K., Nishiyama, M., Ishizawa, S., & Shimada, M. (2023) · The Journal of Medical Investigation · doi:10.2152/jmi.70.66 · Cited by 3
Han, M., Lv, G., Nie, H., Shen, T., Niu, Y., Li, X., Chen, M., Xia, Z., Li, W., Ding, C., et al. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/033480 · Cited by 4
“and ectopic expression of the cyclin-dependent kinase inhibitors (CDKIs) (Rodier and Campisi 2011).”
BackgroundWang, Z., Wu, X., Dai, Q., Liu, Z., Zhao, C., Wei, L. T., Zhao, Y., Li, L., & Wang, X. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103666 · Cited by 4
Cancers in Children Ages 8 to 12 Are Injury-Related
Walen, K. H. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.62020 · Cited by 3
“A type of co-operation known as, antagonistic pliotropy, also occurs among neighboring cells and “cancer to be” cells [24].”
BackgroundDamage-Induced Senescent Immune Cells Regulate Regeneration of the Zebrafish Retina
Patton, J. G., Konar, G. J., Flickinger, Z., Sharma, S., Vallone, K. T., Lyon, C. E., Doshier, C., Lingan, A. L., & Lyon, W. (2024) · doi:10.59368/agingbio.20240021 · Cited by 4
“We then stained tissue sections for SA-β Gal, a pH-dependent lysosomal marker of senescent cells 53–55 .”
Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells
Hori, N., Kawamoto, S., Uemura, K., Kinugasa‐Katayama, Y., Okumura, Y., Tanaka, K., Park, J. H., Wakita, M., Motooka, D., Ohtani, N., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00802-8 · Cited by 3
“However, given the multifaceted roles of cellular senescence (Grosse et al, 2020; Rodier and Campisi, 2011), a precise understanding of their in vivo functions is essential for the rational and safe targeting of senescent cells.”
Glutathione transferase P silencing promotes neuronal differentiation of retinal R28 cells
Sciarretta, F., Fulci, C., Palumbo, C., Aquilano, K., Pastore, A., Iorio, E., Lettieri‐Barbato, D., Cicconi, R., Minutolo, A., Parravano, M., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28246 · Cited by 3
“Decline in proliferation rate and increase in cell size may result from differentiation or replicative senescence (Rodier & Campisi, 2011).”
BackgroundКукушкин, А. Н., Svetlikova, S. B., Aksenov, N., & Поспелов, В. А. (2023) · Cell and Tissue Biology · doi:10.1134/s1990519x23020098 · Cited by 3
“Senescent cells do not divide, but still remain viable and secrete various growth factors and cytokines that maintain the so-called “secretory phenotype” (SASP) (Rodier and Campisi, 2011; Laberge et al., 2015).”
BackgroundCellular senescence and chronic inflammation
Ohtani, N. (2014) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.37.390 · Cited by 3
Pharmacological CDK4/6 inhibition unravels a p53-induced secretory phenotype in senescent cellsPreprint
Wang, B., Brandenburg, S. M., Hernandez‐Segura, A., van Vliet, T., Jongbloed, E. M., Wilting, S. M., Ohtani, N., Jager, A., & Demaria, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.05.135715 · Cited by 4
Wang, L., Zhang, H., Chen, J., Xue, X., Yang, C., Gao, T., Xie, Y., Mai, X., & Wang, B. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.107549 · Cited by 5
Metformin: An Old Drug with New Tricks—Promising Role in Vascular Aging and Cardioprotection
Sivakumar, R., Senghor, K. A. A., Vinodhini, V. M., & Kumar, J. S. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01215-3 · Cited by 7
Damage-induced senescent immune cells regulate regeneration of the zebrafish retinaPreprint
Konar, G. J., Flickinger, Z. R., Sharma, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.524296 · Cited by 3
“We then stained tissue sections for Senescence Associated b-Galactosidase (SA-βGal) , a lysosomal marker of senescent cells 51-53 .”
A novel role of Fas in delaying cellular senescence
Saha, C., Li, J., Sun, X., Liu, X., & Huang, G. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13451 · Cited by 4
“Senescent cells are often associated with survival and with permanent structural and functional alterations, they are nonproliferative but at viable state, distinct from G0 quiescence and terminal differentiation [4].”
Background[The effect of deep branches of cervical nerve on motorial function of trapezius muscle].
Wang, F., Wen, Y., & Li, L. (2003) · 华西口腔医学杂志 · Cited by 4
Dietary ingredients inducing cellular senescence in animals and humans: A systematic review
Guan, L., Zdantsevich, K., Sandalova, E., Crasta, K., & Maier, A. B. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112083 · Cited by 4
“Cellular senescence (CS), defined as a state of permanent cell cycle arrest, is recognized as a key hallmark of ageing and the pathogenesis of age-related diseases (Gorgoulis et al., 2019; L ´ opez-Otín et al., 2023; Rodier and Campisi, 2011).”
Novello, G., de Souza, F. F., & Canisso, I. F. (2024) · Animals · doi:10.3390/ani14142100 · Cited by 6
Campisi, J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.04.015 · Cited by 4
“…the growing (albeit still tenuous) links between cellular senescence and aging phenotypes, and the antagonism between tumor suppres- 011 Elsevier Inc. sion and aging in some contexts (Rodier and Campisi, 2011), do tumor-suppressive p53 target genes also play roles in organismal aging and longevity?”
BackgroundSelf-citationA novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191
Zheng, X., Lv, Y., Xu, L., Zhou, D., Yu, L., & Zhao, Z. (2024) · Hereditas · doi:10.1186/s41065-024-00337-9 · Cited by 4
“Cellular senescence leads to stable inhibition of cell growth and serves as a potent antitumor mechanism [58].”
BackgroundSaleh, T., Himsawi, N. M., Rousan, A. A., Alhesa, A., El‐Sadoni, M., Khawaldeh, S., Shahin, N. A., Ghalioun, A. A., Shawish, B., Friehat, K., et al. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120818 · Cited by 3
Longhorne, F. L., Wilkinson, H. N., Hardman, M. J., & Hart, S. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.29.470337 · Cited by 3
Novel Anti-Retroviral Drug Targets: Interfering siRNA and Mitochondrial TERT Expression
Smith‐Sonneborn, J. (2016) · Virology & Mycology · doi:10.4172/2161-0517.1000150 · Cited by 3
“In the absence or low levels of telomerase, telomeres shorten at each cell division; show associated double strand breaks, senescence, replicative division cessation, apoptosis [18].”
BackgroundMelatonin and Its Antiaging Activity: New Approaches and Strategies for Age-Related Disorders
Süzen, S. (2018) · Springer eBooks · doi:10.1007/978-981-13-1699-9_14 · Cited by 3
Steinsaltz, D., Christodoulou, M. D., Cohen, A. A., & Steiner, U. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11394-7 · Cited by 3
Chmielewski, P. P. (2026) · Biogerontology · doi:10.1007/s10522-026-10436-x · Cited by 2
“Cellular senescence is initially a protective response that limits the proliferation of damaged or potentially oncogenic cells, thereby contributing to tumour suppression, tissue remodelling and wound healing (Serrano et al. 1997; Rodier and Campisi 2011; Sikora et al. 2011; Demaria et al. 2014).”
Albanesi, C., Mercurio, L., Bailey, J. T., Glick, A. B., Dellambra, E., Scarponi, C., Pallotta, S., & Madonna, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3209194/v1 · Cited by 2
Sevilla‐Montero, J., Labrousse-Arias, D., Fernández, C., Barreira, B., Mondéjar‐Parreño, G., Cogolludo, A. L., & Calzada, M. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/555953 · Cited by 2
“main senescence pathways, p53‐p21 and p16‐retinoblastoma protein (pRb) [44], along with increased activity of β-galactosidase (β-Gal) and cell hypertrophy are hallmarks for cellular senescence [45].”
BackgroundRadiation Therapy Towards Laser-Driven Particle Beams: An “OMICS” Approach in Radiobiology
Minafra, L., Bravatà, V., Cammarata, F. P., & Forte, G. I. (2016) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-319-31563-8_4 · Cited by 2
Prahlad, V., & Chikka, M. R. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch3 · Cited by 5
T Cell Senescence and Tumor Immunotherapy
Liu, X., & Peng, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_136-1 · Cited by 2
Sedrak, M. S., Knecht, A. K., Strum, S. L., Sun, C., Ding, Y. C., Ji, J., White, T. A., Nyrop, K. A., LeBrasseur, N. K., Neuhausen, S. L., et al. (2023) · medRxiv · doi:10.1101/2023.05.06.23289535 · Cited by 3
Inflammaging Signaling in Health Span and Life Span Regulation
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00027-7 · Cited by 3
Kochetkova, E. Y., Blinova, G. I., Zubova, S. G., et al. (2017) · Cell and Tissue Biology · doi:10.1134/s1990519x1704006x · Cited by 2
“In this condition, senescent cells retain viability, but their proliferation is completely suppressed (Rodier and Campisi, 2011).”
BackgroundLiang, W., Chen, X., Wu, T., Zheng, X., Zeng, S., Zhou, Q., Ma, W., Lin, H., & Sun, D. (2026) · iMetaMed · doi:10.1002/imm3.70028 · Cited by 2
Dumont, P. (2016) · Virulence · doi:10.1080/21505594.2016.1162370 · Cited by 2
“can be seen as a host defense mechanism, instructing “damaged” cells to cease proliferation.(10,11,19,20) However, excessive accumulation of senescent cells in a”
BackgroundInfluentialEverything Old is Neu Again: Cellular Senescence in HER2-Positive Breast Cancer
Sledge, G. W., & Pegram, M. D. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv091 · Cited by 2
Nagaratnam, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-96998-5_1 · Cited by 2
Nanić, L., Vidaček, N. Š., Ravlić, S., Šatović-Vukšić, E., Huzak, M., & Rubelj, I. (2017) · Biogerontology · doi:10.1007/s10522-017-9736-2 · Cited by 2
The relationship between CXC chemokines and cellular senescence: from mechanisms to therapy
Kang, Y., Zhang, X., & Cui, X. (2026) · Biogerontology · doi:10.1007/s10522-026-10404-5 · Cited by 6
“Oncogene-induced senescence (OIS) is a protective mechanism that halts the progression of pre-cancerous lesions into cancer (Rodier and Campisi 2011).”
Phase separation of MRG15 delays cellular senescence
Li, Y., Jin, X., Yu, C., Zuo, M., Hong, L., Wang, M., Zhao, C., Wu, A., Wang, J., Ju, Z., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08071-2 · Cited by 5
Biomarkers of Replicative Senescence Revisited
Nehlin, J. O. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_12 · Cited by 2
“Cellular senescence might participate in up to four complex biological processes including tumor suppression, tumor promotion, aging, and tissue repair, some of which have apparently opposing effects (Rodier and Campisi 2011).”
BackgroundCurrent Methodologies to Assess Cellular Senescence in Cancer
Laouris, P., & Muñoz‐Espín, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_2 · Cited by 4
Glover, M., Maher, J. F., & Davies, D. M. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2622794 · Cited by 3
“72 The DDR also induces upregulation of NKG2DL, permitting surveillance and removal by immune cells.”
InfluentialMutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns
Yavuz, B. R., Sahin, U., Jang, H., Nussinov, R., & Tunçbağ, N. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013351 · Cited by 3
Nakamichi, S., Yamada, L., Roselle, C., Horikawa, I., June, C. H., & Harris, C. C. (2025) · GeroScience · doi:10.1007/s11357-025-01819-y · Cited by 4
“Given the physiological roles of cellular senescence in tumor suppression, embryonic development, wound healing, and tissue regeneration [1–7], the Δ133p53α-mediated inhibition of cellular senescence requires strategic planning for appropriate timing and duration, organ-specific targeting, and the…”
Molecular signaling and clinical implications in the human aging-cancer cycle
Rezaeian, A.-H., & Wei, W. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.08.003 · Cited by 3
Oncogene-induced senescence in meningiomas—an immunohistochemical study
Mijajlović, V., Miler, M., Ilić, R., Rašić, D., Dunđerović, D., Raičević, S., Soldatović, I., Luka, S. R. D., & Manojlović-Gačić, E. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04532-y · Cited by 2
Suzuki, T., Tetsuka, R., Iwasaki, A., Shimura, T., Hirayama, R., & Nakamura, A. (2024) · Advances in Redox Research · doi:10.1016/j.arres.2024.100114 · Cited by 2
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex
Huang, X., Zhao, Y. T., Wei, M., Zhuge, R., & Zheng, X. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad015 · Cited by 2
Ciornei, R. T., Hong, S., Fang, Y., Zhu, Z., & Braley‐Mullen, H. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.04.006 · Cited by 2
Cellular Senescence and Stem Cell Niche
Krause, A., Conboy, M. J., & Conboy, I. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802734-9.00012-3 · Cited by 5
The intensities of canonical senescence biomarkers integrate the duration of cell-cycle withdrawal
(2023) · doi:10.1101/2023.03.18.533242 · Cited by 2
“Since no single senescence marker is unique to senescence, multiplexing multiple markers in single cells has been suggested as a new goal to identify senescent cells more accurately (3,5).”
BackgroundEndothelial CLEC-1b plays a protective role against cancer hematogenous metastasis
Yamazaki, E., Ikeda, K., Urata, R., Ueno, D., Katayama, A., Ito, F., Ikegaya, H., & Matoba, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149819 · Cited by 3
Elevation of Ceramide in Senescence: Role of Sphingolipid Metabolism
Venable, M. E. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_9 · Cited by 3
The Emerging Role of Senolysis in Atherosclerosis
Vagena, S., Theocharous, G., Theodorou, A., Pantelis, P., Gravanis, M., Tscheuschner, L., Theodorou, A., Galyfos, G. C., Sigala, F., Lаgopati, N., et al. (2025) · Medicina · doi:10.3390/medicina61122137 · Cited by 3
“Despite that cellular senescence is characterized by various common mechanisms and features with aging, it constitutes a different phenomenon [34].”
T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age‐Related Diseases
Richter, L., Dias-Ferreira, J., Ramos, G. C., & Ashour, D. (2026) · Immunological Reviews · doi:10.1111/imr.70125 · Cited by 5
“Persistent SASP modifies tissue microenvironments, propagates cellular senescence in neighboring cells, and exacerbates immune dysfunction [89, 90].”
Reduced RNA turnover as a driver of cellular senescence
(2019) · doi:10.1101/800128 · Cited by 2
A Platinum‐Aluminum Bimetallic Salen Complex for Pro‐senescence Cancer Therapy
Tang, J., Yang, Y., Yin, H., Ma, B., Zhu, M., Yang, Z., Peng, X., Jia, F., Zhao, Y., Wang, F., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400105 · Cited by 2
Chen, X., Li, S., Lu, Q., Li, Y., Zhu, M., Zhang, S., Fang, Y., Wen, C., Yang, D., Fan, P.-L., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03852-7 · Cited by 2
“The p53 signaling pathway is essential in regulating cell cycle progression, apoptosis, DNA repair, and cellular senescence, establishing it as a key tumor suppressor mechanism in cancers such as breast cancer [26–29].”
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.